Harmony Biosciences
HRMY
HRMY
241 hedge funds and large institutions have $2.78B invested in Harmony Biosciences in 2022 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 94 increasing their positions, 66 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
241
Holders Change
+39
Holders Change %
+19.31%
% of All Funds
3.89%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
55
Increased
94
Reduced
66
Closed
15
Calls
$882K
Puts
$1.11M
Net Calls
-$225K
Net Calls Change
-$5.54M
Top Buyers
| 1 |
1
Aberdeen Group
Edinburgh,
United Kingdom
|
$38.1M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$92.3M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$179M |
| 4 |
4
D.E. Shaw & Co
New York
|
$12.3M |
| 5 |
5
Millennium Management
New York
|
$9.53M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
251
Acadian Asset Management
Boston,
Massachusetts
| – | -$120K | -2,724 | Closed |
|
252
Simplex Trading
Chicago,
Illinois
| – | -$32K | -730 | Closed |
|
|
NP
253
Newlight Partners
New York
| – | -$7K | -151 | Closed |
|
|
MAM
254
Meeder Asset Management
Dublin,
Ohio
| – | -$4K | -101 | Closed |
|
|
MFT
255
Moisand Fitzgerald Tamayo
Orlando,
Florida
| – | -$1K | -26 | Closed |
|